External Infusion Pumps Final LCD (L33794) and Response to Comments (RTC) Article Published

Joint DME MAC Publication

Today, the DME MACs published the External Infusion Pumps Final LCD (L33794) and LCD-related Policy Article (PA) (A52507). The policy extends coverage of Xembify® as reasonable and necessary for the treatment of beneficiaries with a diagnosis of primary immune deficiency (PID) disease, when coverage criteria are met. The posting of the final LCD marks the beginning of the 45-day notice period. The final LCD will be effective May 31, 2020.

The DME MACs have also posted a response to all written comments received during the comment period, in a Response to Comments (RTC) Article (A58071).

Please refer to each DME MAC website for additional information about policy development and copies of the final LCD.


Last Updated May 26 , 2023